As 3D bioprinting reaches new levels of precision, scalability, and automation, the conversation is moving beyond what we can print to what matters biologically.
While advances in bioprinting hardware have significantly improved printing precision and complexity, bioink development remains a major bottleneck to achieving functional tissue constructs1. We’re no longer limited by the machines in the same way; we’re limited by the materials we feed them.
Printers can now build impressively complex living structures, but bioinks haven’t kept pace. The real bottleneck is developing 3D bioink formulations that behave reliably during manufacturing and recreate the kind of cellular microenvironments biology recognizes.
Striking that balance is becoming the challenge for 3D biofabrication, and it’s what will ultimately unlock more advanced applications like organoid bioprinting, organ-on-chip platforms, and truly translational tissue engineering2.
| Printability The Hardware Needs |
Functionality The Biological Needs |
|---|---|
| Smooth Extrusion: Material flows easily through the printer nozzle without clogging. | Cell Viability: The environment is gentle enough to keep living cells alive during printing. |
| Shape Fidelity: The bioink holds its shape and stays upright immediately after being printed. | ECM Mimicry: Replicates the native tissue environment so cells can signal, grow, and migrate. |
| Structural Integrity: The printed structure does not collapse under its own weight. | Biocompatibility: Non-toxic materials that support cell attachment and long-term tissue growth. |
Shifting Expectations in Bioink Performance
While 3D bioprinting moves beyond proof-of-concept studies and toward scalable, translational applications, expectations for bioinks are rapidly evolving.
The field is no longer looking for materials that simply make printing possible. It needs bioinks that deliver reliable, predictable performance across research, development, and manufacturing environments.
Reproducibility is becoming a benchmark for success, as demand grows for materials with well-characterized compositions, tightly controlled properties, and minimal batch-to-batch variability to optimise cell viability in bioprinting3.
At the same time, the next generation of tissue models is placing greater demands on biological performance. Bioinks are expected to do far more than provide a printable scaffold. They must actively support cellular organization, guide differentiation, and promote tissue-specific function, all while maintaining the mechanical properties required for increasingly complex 3D biofabrication workflows1,2.
These scientific challenges are unfolding alongside a broader industry shift toward automation and scale. Laboratories are now adopting higher-throughput workflows and more advanced bioprinting platforms, meaning that bioinks must integrate seamlessly into automated processes and perform consistently under increasingly standardized manufacturing conditions.
The future of bioprinting will depend not only on the sophistication of the hardware, but on the ability of bioinks to bridge the gap between biological complexity and manufacturing reliability.
Why Collagen is the Ideal Extracellular Matrix (ECM) for Bioinks
As the principal structural protein of the extracellular matrix (ECM), collagen provides more than a scaffold for cells. It delivers essential biological signals that regulate cell adhesion, migration, proliferation, and differentiation5.
This unique combination of structural and biological functionality positions collagen as a critical material for bioink in 3D bioprinting, where achieving extracellular matrix mimicry depends on balancing 3D biofabrication requirements with the ability to support native-like cellular behavior.
Overcoming Batch-to-Batch Variability in Collagen Bioink Production
The future of bioprinting will be defined by the biological intelligence of the materials that enable it. That makes collagen bioink formulation critical.
The way collagen is sourced, purified, processed, and formulated directly shapes the performance of the final bioink, influencing everything from printability and gelation behavior to mechanical integrity, construct stability, cellular response, and cell viability in bioprinting applications3,6.
As the industry pushes toward more predictive tissue models, scalable manufacturing, and clinical translation, bioinks must evolve from passive carriers to active drivers of cellular function.
Success will not be measured by structure complexity, but by how the chosen materials help replicate the biology we are trying to understand, engineer, and heal.
References
- Debnath S, Agrawal A, Jain N, Chatterjee K, Player DJ. Collagen as a Bio-Ink for 3D Printing: A Critical Review. Journal of Materials Chemistry B. 2025;13:1890–1919.
- Groll J, Boland T, Blunk T, et al. Biofabrication: Reappraising the Definition of an Evolving Field. Biofabrication. 2016;8(1):013001.
- Castilho M, Levato R, Bernal PN, et al. Advances and Future Perspectives in Extrusion-Based Bioprinting. Nature Reviews Materials. 2021;6:36–54.
- Wang H, et al. Novel Approaches for the 3D Printing of Collagen-Sourced Biomaterials: Challenges and Emerging Strategies. Gels. 2025;11(9):745.
- Liu S, Pei M. Collagen-Based Biomaterials for Tissue Engineering Applications. Materials Today Bio. 2023;18:100530.
- Kim MH, Lee H, Lee JH, et al. pH Modification of High-Concentrated Collagen Bioinks as a Factor Affecting Cell Viability, Mechanical Properties and Printability. International Journal of Molecular Sciences. 2021;22(22):12394.
